| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 109,492 | 114,565 | 110,316 | 132,551 | | Cost of Revenue | 83,023 | 94,558 | 86,590 | 99,373 | | | Gross Profit | 26,469 | 20,007 | 23,726 | 33,178 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,943 | 26,359 | 27,686 | 28,219 | | Non Recurring | (2) | 1,470 | 5,778 | 3 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,528 | (7,822) | (9,738) | 4,956 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (778) | (1,584) | 46 | 2,587 | | Earnings Before Interest And Taxes | 2,750 | (9,406) | (9,692) | 7,543 | | Interest Expense | 1,145 | 1,111 | 1,130 | 1,183 | | Income Before Tax | 1,605 | (10,517) | (10,822) | 6,360 | | Income Tax Expense | (310) | (111) | 563 | 426 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,915 | (10,406) | (11,385) | 5,934 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,915 | (10,406) | (11,385) | 5,934 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,915 | ($10,406) | ($11,385) | $5,934 |
|
0.01% Nasdaq 
0.51%
Income Statement
